Clinical Trials Go Digital

| March 6, 2020

article image
Today, more than 90% of new drugs fail clinical trials in the US, and those that do succeed can take upwards of seven years to reach FDA approval. Yet clinical trials, unlike other areas of healthcare, remain relatively untouched by digital innovations that could improve their success and efficiency.

Spotlight

R-Health

R-Health delivers more effective care and a better patient experience – all at a lower cost. We partner with employers, insurance companies, and healthcare brokers to offer primary care that’s truly collaborative. We deliver value-based healthcare two ways: R-Health Accountable Care, our commercial ACO, and R-Health Direct Primary Care, our innovative membership-based model that provides members with the care they deserve.

OTHER ARTICLES

Comparing HydroxyChloroquine Trials

Article | April 1, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | April 1, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 1, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Pharmacist eCare Plan - the newest disrupter in health data exchange?

Article | April 1, 2020

Every member of the health care team shares a common goal of optimizing patient outcomes. Yet each specialty and position of the healthcare team has a unique workflow facilitated by various tools, from an operative report to a progress note. In this regard the pharmacist plays a pivotal function in medication management and requires documentation specific to that role. The Pharmacist eCare Plan (PeCP) allows for an interoperable note to be used in the pharmacy to assist in the exchange of patient information, including active medication list, laboratory results, and payer information. To allow for this, a new type of clinical document architecture for the PeCP was created and standardized for use across pharmacies.

Read More

Spotlight

R-Health

R-Health delivers more effective care and a better patient experience – all at a lower cost. We partner with employers, insurance companies, and healthcare brokers to offer primary care that’s truly collaborative. We deliver value-based healthcare two ways: R-Health Accountable Care, our commercial ACO, and R-Health Direct Primary Care, our innovative membership-based model that provides members with the care they deserve.

Events